Grifols (GRFS) Long-Term Investments (2009 - 2025)

Grifols (GRFS) posted Long-Term Investments of $112.9 million for Q4 2025, up 53.14% quarter-over-quarter from $73.7 million in Q4 2024, and up 53.14% year-on-year from $73.7 million in Q4 2024.

Grifols (GRFS) Long-Term Investments (2009 - 2025) Analysis & Trends

Grifols (GRFS) has reported Long-Term Investments for 16 consecutive years, with $112.9 million the latest figure, recorded in Q4 2025.

  • Long-Term Investments for Q4 2025 came in at $112.9 million, up 53.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $112.9 million (up 53.14% YoY), and the FY2025 annual result was $112.9 million, up 1781.87% from the prior year.
  • Long-Term Investments was $112.9 million for Q4 2025 at Grifols, up from $73.7 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $1.8 billion in Q4 2021 and troughed at $73.7 million in Q4 2024.
  • Average Long-Term Investments over 5 years is $786.5 million, with a median of $453.0 million recorded in 2023.
  • Year-over-year, Long-Term Investments surged 423.86% in 2021 and sank 83.72% in 2024.
  • Over 5 years, Long-Term Investments stood at $1.8 billion in 2021, then dropped by 13.39% to $1.5 billion in 2022, then sank by 70.36% to $453.0 million in 2023, then tumbled by 83.72% to $73.7 million in 2024, then soared by 53.14% to $112.9 million in 2025.
  • Per Business Quant data, the three most recent Long-Term Investments figures were $112.9 million in Q4 2025, $73.7 million in Q4 2024, and $453.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 3.12 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 268.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -12.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 1.11 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 983.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 1.63 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -24.00 Mn
10 Grifols - - - 112.91 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 112.91 Mn
Dec 31, 2024 73.73 Mn
Dec 31, 2023 452.97 Mn
Dec 31, 2022 1.53 Bn
Dec 31, 2021 1.76 Bn
Dec 31, 2020 -544.88 Mn
Sep 30, 2020 194.29 Mn
Mar 31, 2020 504.50 Mn
Dec 31, 2019 126.71 Mn
Sep 30, 2019 156.09 Mn
Mar 31, 2019 147.46 Mn
Dec 31, 2018 258.99 Mn
Sep 30, 2018 15.48 Mn
Jun 30, 2018 6.84 Mn
Mar 31, 2018 134.15 Mn
Dec 31, 2017 257.87 Mn
Jun 30, 2017 11.32 Mn
Dec 31, 2016 4.05 Mn
Sep 30, 2016 -14.67 Mn
Jun 30, 2016 -18.88 Mn